CureVac (NASDAQ:CVAC) Earns “Market Outperform” Rating from JMP Securities

CureVac (NASDAQ:CVAC – Get Free Report)‘s stock had its “market outperform” rating restated by investment analysts at JMP Securities in a research report issued to clients and investors on Friday,Benzinga reports. They presently have a $16.00 price target on the stock. JMP Securities’ price objective suggests a potential upside of 338.36% from the stock’s current […]

Leave a Reply

Your email address will not be published.

Previous post Truist Financial Forecasts Strong Price Appreciation for CyberArk Software (NASDAQ:CYBR) Stock
Next post Charles & Colvard, Ltd. (NASDAQ:CTHR) Coverage Initiated at StockNews.com